Cargando…
Sex-related differences in the efficacy of immune checkpoint inhibitors in malignancy: a systematic review and meta-analysis
Although disease susceptibility is known to differ between men and women, it is controversial whether the efficacy of immune checkpoint inhibitors for malignancies also differs between the sexes. We conducted a meta-analysis to explore the impact of sex on immune checkpoint inhibitor treatment outco...
Autores principales: | Lai, Li-Ting, Gu, Wei-Guo, Hu, Ming-Bin, Wang, Wei-Jia, Wang, Shan-Shan, Huai, Ya-Jun, Mei, Jin-Hong, Wang, Chun-Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221333/ https://www.ncbi.nlm.nih.gov/pubmed/34086601 http://dx.doi.org/10.18632/aging.203100 |
Ejemplares similares
-
The efficacy of immune checkpoint inhibitors in thoracic malignancies
por: Remon, Jordi, et al.
Publicado: (2021) -
Targeting immune checkpoints in malignant glioma
por: Zhang, Xuhao, et al.
Publicado: (2016) -
Biomarkers for predicting the efficacy of immune checkpoint inhibitors
por: Wang, Chengji, et al.
Publicado: (2022) -
Future of immune checkpoint inhibitors: focus on tumor immune microenvironment
por: Jia, Yunlong, et al.
Publicado: (2020) -
Immune Checkpoint Inhibitors in Special Populations
por: Shan, Qianyun, et al.
Publicado: (2021)